Inhibition of Src tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells Article

Duxbury, MS, Ito, H, Zinner, MJ et al. (2004). Inhibition of Src tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells . CLINICAL CANCER RESEARCH, 10(7), 2307-2318. 10.1158/1078-0432.CCR-1183-3

cited authors

  • Duxbury, MS; Ito, H; Zinner, MJ; Ashley, SW; Whang, EE

sustainable development goals

authors

publication date

  • April 1, 2004

published in

keywords

  • 2',2'-DIFLUORODEOXYCYTIDINE GEMCITABINE
  • CARCINOMA-CELLS
  • DNA-SYNTHESIS
  • DOWN-REGULATION
  • HUMAN CANCER-CELLS
  • IN-VITRO
  • INDUCED APOPTOSIS
  • Life Sciences & Biomedicine
  • Oncology
  • REDUCTASE M2 SUBUNIT
  • RIBONUCLEOTIDE REDUCTASE
  • Science & Technology
  • TRANSCRIPTION FACTOR

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 2307

end page

  • 2318

volume

  • 10

issue

  • 7